Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Pfizer's filgrastim biosimilar Nivestym

July 24, 2018

Imugene advances preclinical development of new PD-1 cancer vaccine KEY-Vaxx

July 24, 2018

Koutif Therapeutics completes IND-enabling studies with Fbxo3 inhibitor KT-1002

July 24, 2018

Grant supports Poseida's late-stage preclinical development of P-PSMA-101

July 24, 2018

Vasopressin inhibition decreases mortality in jet-lagged mice

July 24, 2018

CRISPR: shoddy repairs?

July 24, 2018

Asceneuron presents phase I results for ASN-120290

July 23, 2018

FDA approves single-dose Krintafel for radical cure of P. vivax malaria

July 23, 2018

New phase I study evaluates MK-4830 alone and with pembrolizumab for advanced solid tumors

July 23, 2018

ShanghaiTech University synthesizes PIWIL4 inhibitors

July 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...